(Q36810953)

English

Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial

scientific article published on January 1994

Statements

Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial (English)
Gershlick AH
Spriggins D
Davies SW
Syndercombe Court YD
Timmins J
Timmis AD
Rothman MT
Layton C
Balcon R
1 January 1994
7-15

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit